On behalf of Gicc-HF
France
Research Article
Medical Inertia in the Optimization of Heart Failure Treatment after Discharge and its Relationship to Outcome
Author(s): Berthelot E, Eicher JC, Salvat M, Seronde MF, de Groote, Jondeau G, Galinier M, Donal E, Damy T, Jourdain P, Bauer F, Isnard R, Trochu JN, Damien Logeart and On behalf of Gicc-HFBerthelot E, Eicher JC, Salvat M, Seronde MF, de Groote, Jondeau G, Galinier M, Donal E, Damy T, Jourdain P, Bauer F, Isnard R, Trochu JN, Damien Logeart and On behalf of Gicc-HF
Background: After discharge, patients with Acute Heart Failure (AHF) have a high risk of early re-admission and death. Many patients are discharged early before treatment has been optimized. By using a multicenter cohort of AHF patients, we analyzed changes in evidence-based HF medication between admission, discharge and early follow-up as well as their links to mortality. Methods: Clinical data and medications were collected during hospitalization. Changes in medication during the 3 months following discharge as well as the rate of all-cause mortality at one year were analyzed. Results: Among survivors at 3 months, 275 patients with LVEF ≤ 40% were included (age 72 ± 14 y). Between admission and discharge, usage of angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) and beta bl.. View More»
DOI:
10.4172/2375-4273.1000221